WallStreetZenWallStreetZen

NASDAQ: DFTX
Definium Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Definium Therapeutics revenue was $0.00 for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 30, 2025 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, DFTX annual revenue was $0.0, with N/A growth year-over-year.

DFTX revenue history

Current Revenue
$0.0
Current Earnings
-$168.1M
Current Profit Margin
0%

Be the first to know when DFTX announces revenue.

DFTX Revenue History By Year

DFTX Yearly RevenueDFTX RevenueDFTX ChangeDFTX Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31N/AN/AN/A

1 of 1

Definium Therapeutics Revenue FAQ

What was DFTX's revenue last quarter?

On Invalid Date, Definium Therapeutics (NASDAQ: DFTX) reported Q3 2025 revenue of $0.00 up N/A year over year. In the same quarter last year, Definium Therapeutics's revenue was $0.00.

What was Definium Therapeutics's revenue in 2024?

Definium Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Definium Therapeutics make in a day?

Based on Definium Therapeutics annual revenue for the past five years, DFTX makes an average of $0.00 per day.

What was Definium Therapeutics's annual revenue growth in the past year?

As of Q1 2026, Definium Therapeutics's revenue has grown null year over year. Definium Therapeutics's revenue in the past year totaled $0.00.

How much does Definium Therapeutics make in a year?

Definium Therapeutics's revenue by year for the past five years is:
  • Definium Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Definium Therapeutics's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
  • Definium Therapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Definium Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Definium Therapeutics's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.